The programme is open to students who have obtained an honour’s degree (Level 8) or equivalent in an appropriate discipline (i.e. Engineering or Life Sciences). Other candidates with alternative honours degrees and relevant experience in the Biopharmaceutical / Pharmaceutical industry (typically 5 years duration in a GMP environment) may apply for consideration through the IT Sligo RPL (Recognised Prior Learning) process. Applicants whose first language is not English should provide evidence of English language proficiency. For further information on English language requirements click here.
On completion of this module the learner will/should be able to;
1.Demonstrate they have detailed knowledge and understanding of the background to Industry 4.0 and emerging needs in the biopharma sector, the source and quality of existing data and applicability of industry4.
2.Demonstrate they have detailed knowledge and understanding of the application of predictive modelling, automation systems, PLCs, robotics, vision systems
3.Evaluate embedded systems, the internet of things (IoT) and the cyber-physical systems (sensors, control boards) necessary for data acquisition
4.Formulate judgements on the relevant value and application of existing data sources, design tools, digital twins, simulation models, and augmented reality/virtual reality.
5.Integrate knowledge and formulate judgements on the application of robotics and industrial vision systems to biomanufacturing operations.
Learn from world renowned academic staff in Ireland’s leading, future focused and globally recognised colleges.
Gain an accredited NFQ qualification/micro credential that you may count towards a full award if you so wish in the future.
Previous modules may be used as recognition of prior learning towards Advance Centre degree programmes.
Equip yourself with the latest in demand skillset, tools, know-how and knowledge to succeed in your career.
Gain a competitive edge, influence growth and steer strategic goals in your organisation upon completion of your studies with the Advance Centre.
